APO Research
Talk to an analyst

APO RESEARCH · REPORT

Postbiotics CDMO Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Postbiotics CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026188 pages

Choose your research edition.

Industry ResearchPostbiotics CDMO Service Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Postbiotics CDMO Service Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Postbiotics CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Postbiotics CDMO Service Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Postbiotics CDMO Service Market Analysis and Forecast 2026-2032226 pages · $4,950 USD

Market perspective

The global Postbiotics CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Postbiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Postbiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Postbiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Postbiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Postbiotics CDMO Service include ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma and Sacco System, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Postbiotics CDMO Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Postbiotics CDMO Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Postbiotics CDMO Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Postbiotics CDMO Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Postbiotics CDMO Service Segment by Company

ILDONG Bioscience Co., Ltd.

Bioprox Healthcare

Exden

JuneYao Group (BioGrowing)

dsm-firmenich (Adare Pharma Solutions)

Sirio Pharma

Sacco System

Postbiotics CDMO Service Segment by Type

Oral Dosage Forms (Capsules And Tablets)

Powders and Granules

Liquid Preparations

Postbiotics CDMO Service Segment by Application

Medicines and Health Products

Food

Pet Food

Cosmetics

Postbiotics CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Postbiotics CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Postbiotics CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Postbiotics CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Postbiotics CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Postbiotics CDMO Service industry.

Chapter 3: Detailed analysis of Postbiotics CDMO Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Postbiotics CDMO Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Postbiotics CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Dosage Forms (Capsules And Tablets) Table 3. Key Players of Powders and Granules Table 4. Key Players of Liquid Preparations Table 4. Global Postbiotics CDMO Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medicines and Health Products Table 6. Key Players of Food Table 7. Key Players of Pet Food Table 8. Key Players of Cosmetics Table 9. Global Postbiotics CDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Postbiotics CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Postbiotics CDMO Service Market Share by Region (2021-2026) Table 12. Global Postbiotics CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Postbiotics CDMO Service Market Share by Region (2027-2032) Table 14. Postbiotics CDMO Service Industry Trends Table 15. Postbiotics CDMO Service Industry Drivers Table 16. Postbiotics CDMO Service Industry Opportunities and Challenges Table 17. Postbiotics CDMO Service Industry Restraints Table 18. Global Postbiotics CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Postbiotics CDMO Service Revenue Market Share by Company (2021-2026) Table 20. Global Postbiotics CDMO Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Postbiotics CDMO Service Key Company Head Office and Area Served Table 22. Global Postbiotics CDMO Service Company, Product Type & Application Table 23. Global Postbiotics CDMO Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Postbiotics CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Postbiotics CDMO Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Postbiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Postbiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Postbiotics CDMO Service Revenue Market Share by Type (2021-2026) Table 30. Global Postbiotics CDMO Service Revenue Market Share by Type (2027-2032) Table 31. Global Postbiotics CDMO Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Postbiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Postbiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Postbiotics CDMO Service Revenue Market Share by Application (2021-2026) Table 35. Global Postbiotics CDMO Service Revenue Market Share by Application (2027-2032) Table 36. ILDONG Bioscience Co., Ltd. Company Information Table 37. ILDONG Bioscience Co., Ltd. Business Overview Table 38. ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Product Portfolio Table 40. ILDONG Bioscience Co., Ltd. Recent Development Table 41. Bioprox Healthcare Company Information Table 42. Bioprox Healthcare Business Overview Table 43. Bioprox Healthcare Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bioprox Healthcare Postbiotics CDMO Service Product Portfolio Table 45. Bioprox Healthcare Recent Development Table 46. Exden Company Information Table 47. Exden Business Overview Table 48. Exden Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Exden Postbiotics CDMO Service Product Portfolio Table 50. Exden Recent Development Table 51. JuneYao Group (BioGrowing) Company Information Table 52. JuneYao Group (BioGrowing) Business Overview Table 53. JuneYao Group (BioGrowing) Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. JuneYao Group (BioGrowing) Postbiotics CDMO Service Product Portfolio Table 55. JuneYao Group (BioGrowing) Recent Development Table 56. dsm-firmenich (Adare Pharma Solutions) Company Information Table 57. dsm-firmenich (Adare Pharma Solutions) Business Overview Table 58. dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Product Portfolio Table 60. dsm-firmenich (Adare Pharma Solutions) Recent Development Table 61. Sirio Pharma Company Information Table 62. Sirio Pharma Business Overview Table 63. Sirio Pharma Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Sirio Pharma Postbiotics CDMO Service Product Portfolio Table 65. Sirio Pharma Recent Development Table 66. Sacco System Company Information Table 67. Sacco System Business Overview Table 68. Sacco System Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Sacco System Postbiotics CDMO Service Product Portfolio Table 70. Sacco System Recent Development Table 71. North America Postbiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 72. North America Postbiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 73. North America Postbiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 74. North America Postbiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 75. North America Postbiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Postbiotics CDMO Service Market Size by Country (2021-2026) Table 77. North America Postbiotics CDMO Service Market Size by Country (2027-2032) Table 78. Europe Postbiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 79. Europe Postbiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 80. Europe Postbiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 81. Europe Postbiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 82. Europe Postbiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Europe Postbiotics CDMO Service Market Size by Country (2021-2026) Table 84. Europe Postbiotics CDMO Service Market Size by Country (2027-2032) Table 85. China Postbiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 86. China Postbiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 87. China Postbiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 88. China Postbiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 89. Asia Postbiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 90. Asia Postbiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 91. Asia Postbiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 92. Asia Postbiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Postbiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Asia Postbiotics CDMO Service Market Size by Country (2021-2026) Table 95. Asia Postbiotics CDMO Service Market Size by Country (2027-2032) Table 96. South America, Middle East & Africa Postbiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 97. South America, Middle East & Africa Postbiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 98. South America, Middle East & Africa Postbiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 99. South America, Middle East & Africa Postbiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 100. South America, Middle East & Africa Postbiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. South America, Middle East & Africa Postbiotics CDMO Service Market Size by Country (2021-2026) Table 102. South America, Middle East & Africa Postbiotics CDMO Service Market Size by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Postbiotics CDMO Service Product Image Figure 2. Global Postbiotics CDMO Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Postbiotics CDMO Service Market Share by Type: 2025 VS 2032 Figure 4. Oral Dosage Forms (Capsules And Tablets) Image Figure 5. Powders and Granules Image Figure 6. Liquid Preparations Image Figure 7. Global Postbiotics CDMO Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Postbiotics CDMO Service Market Share by Application: 2025 VS 2032 Figure 9. Medicines and Health Products Image Figure 10. Food Image Figure 11. Pet Food Image Figure 12. Cosmetics Image Figure 13. Global Postbiotics CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 15. Global Postbiotics CDMO Service Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Postbiotics CDMO Service Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Postbiotics CDMO Service Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Postbiotics CDMO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Postbiotics CDMO Service Revenue Market Share by Type (2021-2032) Figure 22. Global Postbiotics CDMO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Postbiotics CDMO Service Revenue Market Share by Application (2021-2032) Figure 24. North America Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 25. North America Postbiotics CDMO Service Market Share by Type (2021-2032) Figure 26. North America Postbiotics CDMO Service Market Share by Application (2021-2032) Figure 27. North America Postbiotics CDMO Service Market Share by Country (2021-2032) Figure 28. United States Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 29. Canada Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Postbiotics CDMO Service Market Share by Type (2021-2032) Figure 33. Europe Postbiotics CDMO Service Market Share by Application (2021-2032) Figure 34. Europe Postbiotics CDMO Service Market Share by Country (2021-2032) Figure 35. Germany Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 36. France Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 38. Italy Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 39. Russia Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 41. China Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 42. China Postbiotics CDMO Service Market Share by Type (2021-2032) Figure 43. China Postbiotics CDMO Service Market Share by Application (2021-2032) Figure 44. Asia Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 45. Asia Postbiotics CDMO Service Market Share by Type (2021-2032) Figure 46. Asia Postbiotics CDMO Service Market Share by Application (2021-2032) Figure 47. Asia Postbiotics CDMO Service Market Share by Country (2021-2032) Figure 48. Japan Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 52. India Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 53. Australia Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Postbiotics CDMO Service Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Postbiotics CDMO Service Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Postbiotics CDMO Service Market Share by Country (2021-2032) Figure 58. Brazil Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 63. UAE Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 65. Chile Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Dosage Forms (Capsules And Tablets)
  • Powders and Granules
  • Liquid Preparations
Applications
  • Medicines and Health Products
  • Food
  • Pet Food
  • Cosmetics
Companies covered
  • ILDONG Bioscience Co., Ltd.
  • Bioprox Healthcare
  • Exden
  • JuneYao Group (BioGrowing)
  • dsm-firmenich (Adare Pharma Solutions)
  • Sirio Pharma
  • Sacco System

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Postbiotics CDMO Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Dosage Forms (Capsules And Tablets)
  5. 1.2.3 Powders and Granules
  6. 1.2.4 Liquid Preparations
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Postbiotics CDMO Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Medicines and Health Products
  10. 1.3.3 Food
  11. 1.3.4 Pet Food
  12. 1.3.5 Cosmetics
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Postbiotics CDMO Service Growth Trends by Region
  15. 1.5.1 Global Postbiotics CDMO Service Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Postbiotics CDMO Service Market Size by Region (2021-2026)
  17. 1.5.3 Postbiotics CDMO Service Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Postbiotics CDMO Service Market Dynamics
  1. 2.1 Postbiotics CDMO Service Industry Trends
  2. 2.2 Postbiotics CDMO Service Industry Drivers
  3. 2.3 Postbiotics CDMO Service Industry Opportunities and Challenges
  4. 2.4 Postbiotics CDMO Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Postbiotics CDMO Service Revenue by Company (2021-2026)
  2. 3.2 Global Postbiotics CDMO Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Postbiotics CDMO Service Key Company Head office and Area Served
  4. 3.4 Global Postbiotics CDMO Service Company, Product Type & Application
  5. 3.5 Global Postbiotics CDMO Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Postbiotics CDMO Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Postbiotics CDMO Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Postbiotics CDMO Service Tier 1, Tier 2, and Tier 3
4 Postbiotics CDMO Service Market by Type
  1. 4.1 Global Postbiotics CDMO Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Postbiotics CDMO Service Market Size by Type (2021-2032)
  3. 4.3 Global Postbiotics CDMO Service Market Size Share by Type (2021-2032)
5 Postbiotics CDMO Service Market by Application
  1. 5.1 Global Postbiotics CDMO Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Postbiotics CDMO Service Market Size by Application (2021-2032)
  3. 5.3 Global Postbiotics CDMO Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ILDONG Bioscience Co., Ltd.
  2. 6.1.1 ILDONG Bioscience Co., Ltd. Company Information
  3. 6.1.2 ILDONG Bioscience Co., Ltd. Business Overview
  4. 6.1.3 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Product Portfolio
  6. 6.1.5 ILDONG Bioscience Co., Ltd. Recent Developments
  7. 6.2 Bioprox Healthcare
  8. 6.2.1 Bioprox Healthcare Company Information
  9. 6.2.2 Bioprox Healthcare Business Overview
  10. 6.2.3 Bioprox Healthcare Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bioprox Healthcare Postbiotics CDMO Service Product Portfolio
  12. 6.2.5 Bioprox Healthcare Recent Developments
  13. 6.3 Exden
  14. 6.3.1 Exden Company Information
  15. 6.3.2 Exden Business Overview
  16. 6.3.3 Exden Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Exden Postbiotics CDMO Service Product Portfolio
  18. 6.3.5 Exden Recent Developments
  19. 6.4 JuneYao Group (BioGrowing)
  20. 6.4.1 JuneYao Group (BioGrowing) Company Information
  21. 6.4.2 JuneYao Group (BioGrowing) Business Overview
  22. 6.4.3 JuneYao Group (BioGrowing) Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 JuneYao Group (BioGrowing) Postbiotics CDMO Service Product Portfolio
  24. 6.4.5 JuneYao Group (BioGrowing) Recent Developments
  25. 6.5 dsm-firmenich (Adare Pharma Solutions)
  26. 6.5.1 dsm-firmenich (Adare Pharma Solutions) Company Information
  27. 6.5.2 dsm-firmenich (Adare Pharma Solutions) Business Overview
  28. 6.5.3 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Product Portfolio
  30. 6.5.5 dsm-firmenich (Adare Pharma Solutions) Recent Developments
  31. 6.6 Sirio Pharma
  32. 6.6.1 Sirio Pharma Company Information
  33. 6.6.2 Sirio Pharma Business Overview
  34. 6.6.3 Sirio Pharma Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Sirio Pharma Postbiotics CDMO Service Product Portfolio
  36. 6.6.5 Sirio Pharma Recent Developments
  37. 6.7 Sacco System
  38. 6.7.1 Sacco System Company Information
  39. 6.7.2 Sacco System Business Overview
  40. 6.7.3 Sacco System Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Sacco System Postbiotics CDMO Service Product Portfolio
  42. 6.7.5 Sacco System Recent Developments
7 North America
  1. 7.1 North America Postbiotics CDMO Service Market Size (2021-2032)
  2. 7.2 North America Postbiotics CDMO Service Market Size by Type
  3. 7.2.1 North America Postbiotics CDMO Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Postbiotics CDMO Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Postbiotics CDMO Service Market Share by Type (2021-2032)
  6. 7.3 North America Postbiotics CDMO Service Market Size by Application
  7. 7.3.1 North America Postbiotics CDMO Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Postbiotics CDMO Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Postbiotics CDMO Service Market Share by Application (2021-2032)
  10. 7.4 North America Postbiotics CDMO Service Market Size by Country
  11. 7.4.1 North America Postbiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Postbiotics CDMO Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Postbiotics CDMO Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Postbiotics CDMO Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Postbiotics CDMO Service Market Size (2021-2032)
  2. 8.2 Europe Postbiotics CDMO Service Market Size by Type
  3. 8.2.1 Europe Postbiotics CDMO Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Postbiotics CDMO Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Postbiotics CDMO Service Market Share by Type (2021-2032)
  6. 8.3 Europe Postbiotics CDMO Service Market Size by Application
  7. 8.3.1 Europe Postbiotics CDMO Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Postbiotics CDMO Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Postbiotics CDMO Service Market Share by Application (2021-2032)
  10. 8.4 Europe Postbiotics CDMO Service Market Size by Country
  11. 8.4.1 Europe Postbiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Postbiotics CDMO Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Postbiotics CDMO Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Postbiotics CDMO Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Postbiotics CDMO Service Market Size (2021-2032)
  2. 9.2 China Postbiotics CDMO Service Market Size by Type
  3. 9.2.1 China Postbiotics CDMO Service Market Size by Type (2021-2026)
  4. 9.2.2 China Postbiotics CDMO Service Market Size by Type (2027-2032)
  5. 9.2.3 China Postbiotics CDMO Service Market Share by Type (2021-2032)
  6. 9.3 China Postbiotics CDMO Service Market Size by Application
  7. 9.3.1 China Postbiotics CDMO Service Market Size by Application (2021-2026)
  8. 9.3.2 China Postbiotics CDMO Service Market Size by Application (2027-2032)
  9. 9.3.3 China Postbiotics CDMO Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Postbiotics CDMO Service Market Size (2021-2032)
  2. 10.2 Asia Postbiotics CDMO Service Market Size by Type
  3. 10.2.1 Asia Postbiotics CDMO Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Postbiotics CDMO Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Postbiotics CDMO Service Market Share by Type (2021-2032)
  6. 10.3 Asia Postbiotics CDMO Service Market Size by Application
  7. 10.3.1 Asia Postbiotics CDMO Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Postbiotics CDMO Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Postbiotics CDMO Service Market Share by Application (2021-2032)
  10. 10.4 Asia Postbiotics CDMO Service Market Size by Country
  11. 10.4.1 Asia Postbiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Postbiotics CDMO Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Postbiotics CDMO Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Postbiotics CDMO Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Postbiotics CDMO Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Postbiotics CDMO Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Postbiotics CDMO Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Postbiotics CDMO Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Postbiotics CDMO Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst